The data obtained suggest that under the conditions of MF therapy, which considerably restores male reproduction in T2DM, long-term use of gonadotropins and allosteric LH/hCG-R-agonists may be ineffective and even cause negative consequences. This evidence concerns the gene PLOD1 and type 2 diabetes mellitus.